Co-processed excipients are mixed excipients made by processing two or more medicinal excipients through specific physical processing techniques to achieve specific functions, and should not form new chemical covalent bonds during the processing. In recent years, with the improvement of domestic drug formulation research and development level, the demand for formulation technology and new excipients has been continuously increasing. Domestic excipient enterprises have also focused on the research and development of co processed excipients. ‌

Overview of Market Development

The growth of the global co-processed excipient market is mainly driven by the increasing demand in terminal application fields such as pharmaceuticals and nutritional supplements. At the same time, the rapid development of emerging markets and the acceleration of industrialization have provided more growth opportunities for the co-processed excipient market. According to our research data, the estimated global market size for co-processed excipient in 2024 is $666 million, an increase of 8.87% compared to 2023, and is expected to continue growing to $1015 million by 2029. The CAGR for 2024-2029 is estimated to be 8.79%.

Segmented Market Analysis

From the perspective of product type, according to different processing methods, co-processed excipients can be divided into granulation excipients, solvent evaporation excipients, spray drying excipients and hot-melt extrusion excipients. Among them, spray drying excipients occupy the largest market share, which is estimated to be 52.36% in 2024.

From the perspective of downstream application patterns, co-processed excipients are mainly used in the fields of pharmaceutical and nutraceutical. Among them, the pharmaceutical industry is the largest downstream application market, with an expected application share of 89.59% in 2024.

Source: www.globalmarketmonitor.com

Market Analysis of Major Regions

From a regional perspective, the global co-processed excipient market is dominated by the Americas, Asia Pacific, and Europe. Among them, Europe is the largest consumer market. Data shows that the consumption of co-processed excipients in Europe is expected to reach 5572.9 tons in 2024, accounting for an estimated 44.63% of the global total consumption.

Regions	Consumption (Tons)	Proportion
Americas	4020.8	32.20%
Asia Pacific	2000.4	16.02%
Europe	5572.9	44.63%
Middle East & Africa	892.8	7.15%